Skip to content

High-Resolution Antibody Profile for HLA-DRB3 (Unresolved High-Resolution)

Published: August 9, 2026Updated: August 16, 2026

This test measures antibodies against the HLA-DRB3 gene, which plays a role in immune response and organ compatibility. It helps identify potential immune reactions in transplant candidates or patients with autoimmune conditions.

Quick summary

["This test helps assess compatibility for organ transplants or autoimmune conditions by detecting specific antibodies."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
96675-4
Short code
HLA-DRB345 Unreslvd High Res
Synonyms
HLA-DRB345 Unreslvd High Res
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
high-resolution
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why This Test Might Be Ordered

Your doctor may recommend this test if you’re a candidate for organ transplantation (e.g., kidney, liver) or if you have symptoms like chronic inflammation, organ rejection risks, or autoimmune diseases. It helps ensure a safer transplant match or monitor immune activity.

What to Expect Before the Test

No special preparation is needed unless instructed by your doctor. Blood will be drawn from a vein in your arm. If you’re a transplant candidate, you may need to fast for 8–12 hours before testing.

What the Results Mean

Positive results indicate the presence of antibodies against HLA-DRB3, which may affect transplant compatibility or immune function. Results are interpreted by your healthcare provider in the context of your medical history.

Common Reasons for Testing

This test is often used in transplant medicine to screen donors and recipients for HLA mismatches that could trigger immune rejection. It may also be part of broader antibody panels for autoimmune diseases like lupus or rheumatoid arthritis.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

High-resolution HLA antibody testing is critical for transplant medicine to minimize rejection risks by matching donor-recipient compatibility. In autoimmune conditions, detecting HLA-related antibodies helps guide treatment decisions to reduce flare-ups or organ damage. Results may influence transplant waitlisting, donor selection, or immunosuppressive therapy.

Short name

HLA-DRB3 Antibody Screening (High-Res)

Frequently asked questions

Will this test affect my transplant eligibility?
Possibly. Positive antibodies against HLA-DRB3 may require additional evaluation, such as further testing or adjustments to your transplant profile. Your transplant team will discuss this with you based on your full medical picture.
How long will I need to wait for results?
Results typically take 1–3 business days, depending on lab processing. Your doctor will contact you once they’re ready. If urgent, they may expedite the process.
Can I eat or drink before this test?
No fasting is required unless your doctor specifies otherwise. Follow their instructions for the best accuracy.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy